Trinity Biotech (NASDAQ: TRIB) is one of 25 publicly-traded companies in the “Diagnostic substances” industry, but how does it weigh in compared to its peers? We will compare Trinity Biotech to related businesses based on the strength of its analyst recommendations, valuation, risk, earnings, dividends, profitability and institutional ownership.
Profitability
This table compares Trinity Biotech and its peers’ net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets
Trinity Biotech -40.62% 2.37% 0.99%
Trinity....More>>>